" /> Bv-AVEPC Regimen - CISMeF





Preferred Label : Bv-AVEPC Regimen;

NCIt synonyms : Brentuximab Vedotin with AVE-PC; Brentuximab Vedotin/Cyclophosphamide/Doxorubicin//Etoposide/Prednisone/Vincristine; Brentuximab Vedotin/Doxorubicin/Vincristine/Etoposide/Prednisone/Cyclophosphamide; Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Prednisone-Etoposide/Brentuximab Vedotin Regimen; Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine/Brentuximab Vedotin; Brentuximab Vedotin/Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine Regimen; AVEPC-Adcetris; AVEPC-Adcetris Regimen; AVEPC-Brentuximab Vedotin; Adcetris-Cyclophosphamide/Doxorubicin//Etoposide/Prednisone/Vincristine; Brentuximab Vedotin/Adriamycin/Vincristine/Etoposide/Prednisone/Cyclophosphamide; AVE-PC-Brentuximab Vedotin Regimen; Brentuximab Vedotin with AVEPC Regimen; BV-AVE-PC Regimen; BV-AVEPC;

NCIt definition : A regimen consisting of cyclophosphamide, doxorubicin, etoposide, prednisone, vincristine and brentuximab vedotin used to treat pediatric Hodgkin lymphoma (HL).;

NCI Metathesaurus CUI : CL1904906;

Codes from synonyms : 13998;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
06/07/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.